|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1,3-Dichloro-5,5-dimethylhydantoin | CAS 118-52-5 | ||
| C5H6Cl2N2O2 | RTECS MU0700000 | ||
|
Synonyms & Trade Names Dactin, DDH, Halane |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.2 mg/m3 ST 0.4 mg/m3 | ||
| OSHA PEL�: TWA 0.2 mg/m3 | |||
| IDLH 5 mg/m3 | Conversion | ||
|
Physical Description White powder with a chlorine-like odor. |
|||
|
MW: 197.0 |
BP: ? |
MLT: 270°F |
Sol: 0.2% |
|
VP: ? |
IP: ? |
|
Sp.Gr: 1.5 |
|
Fl.P: 346°F |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities Water, strong acids, easily oxidized materials such as ammonia salts & sulfides |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH/OSHA Up to 2 mg/m3: (APF = 10) Any supplied-air respirator Up to 5 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted canister providing protection against the compound of concern and having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, mucous membrane, respiratory system | |
|
Target Organs
Eyes, respiratory system |
|
| See also: INTRODUCTION |